本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Kiniksa Pharmaceuticals Ltd.

26.97
+0.03000.11%
成交量:21.57萬
成交額:577.22萬
市值:19.68億
市盈率:-114.45
高:27.00
開:27.00
低:26.39
收:26.94
資料載入中...
2025/01/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/13

重要事件披露

Form 8-K - Current report
2024/12/16

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/12/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/27

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/18

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/15

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/15

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/10/29

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/10/29

重要事件披露

Form 8-K - Current report
2024/10/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/10/08

超過5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/10/08

重要事件披露

Form 8-K - Current report
2024/09/23

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/09/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/09/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/08/27

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/07/25

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]